A meta-analysis of cognitive impairment following adult cancer chemotherapy

Neuropsychology

Volumn 28, Issue 5, 2014, Pages 726-740

  Lindner, Oana C ^a   Phillips, Bob ^b   McCabe, Martin G ^a   Mayes, Andrew ^a   Wearden, Alison ^a   Varese, Filippo ^a   Talmi, Deborah ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cancer; Chemo brain; Chemotherapy; Impairment; Neuropsychology

Indexed keywords

ANTINEOPLASTIC AGENT;

AGE; ARTICLE; ATTENTION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVOR; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EFFECT SIZE; FOLLOW UP; HUMAN; INTEGRATION; LONGITUDINAL STUDY; MEMORY DISORDER; META ANALYSIS; METHODOLOGY; MOTOR PERFORMANCE; PRIORITY JOURNAL; QUALITY CONTROL; RECALL; RECOGNITION; SELECTION BIAS; SELECTIVE ATTENTION; STUDY DESIGN; TESTIS CANCER; VERBAL MEMORY; VISUAL MEMORY; BREAST NEOPLASMS; CHEMICALLY INDUCED; FEMALE; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS; TESTICULAR NEOPLASMS;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COGNITION DISORDERS; FEMALE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS; TESTICULAR NEOPLASMS;

EID: 84906936285     PISSN: 08944105     EISSN: 19311559     Source Type: Journal    
DOI: 10.1037/neu0000064     Document Type: Article

References (49)

1. Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7, 192-201.
2. Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K.,. .. Silberfarb, P. M. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493.
3. Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., Kaufman, P. A. (2008). Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Research and Treatment, 110, 143-152.
4. Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Kaufman, P. A. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. Journal of Clinical Oncology, 28, 4434-4440.
5. Ahles, T. A., Saykin, A. J., Noll, W. W., Furstenberg, C. T., Guerin, S., Cole, B., & Mott, L. A. (2003). The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology, 12, 612-619.
6. Anderson-Hanley, C., Sherman, M. L., Riggs, R., Agocha, V. B., & Compas, B. E. (2003). Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. Journal of the International Neuropsychological Society, 9, 967-982.
7. Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). Introduction to meta-analysis. New York, NY: Wiley.
8. Cohen, J. (1992). A power primer. Psychological Bulletin, 112, 155-159.
9. Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., Sunaert, S. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Human Brain Mapping, 32, 480-493.
10. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G.,. Schagen, S. B. (2012). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Human Brain Mapping, 33, 2971-2983.
11. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S., Nederveen, A. J., Schagen, S. B. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32, 1206-1219.
12. Downs, S. H., & Black, N. (1998). The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of Epidemiology Community Health, 52, 377-384.
13. Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315, 629-634.
14. Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L. A., & Phillips, K. A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59, 60-70.
15. Ferguson, R. J., Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., & Mott, L. A. (2007). Cognitive-behavioral management of chemotherapy-related cognitive change. Psycho-Oncology, 16, 772-777.
16. Field, A. P., & Gillett, R. (2010). How to do a meta-analysis. British Journal of Mathematical and Statistical Psychology, 63, 665-694.
17. Freeman, J. R., & Broshek, D. K. (2002). Assessing cognitive dysfunction in breast cancer: What are the tools? Clinical Breast Cancer, 3, Suppl 3, S91-S99.
18. Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., Munzel, K. (2007). Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer, 109, 1905-1913.
19. Higgins, J. P. T., & Green, S. (Eds). (2008). Cochrane handbook for systematic reviews of interventions. Chichester, England: Wiley-Blackwell.
20. Hox, J. (2010). Multilevel analysis: Techniques and applications. New York, NY: Routledge.
21. Hurria, A., Somlo, G., & Ahles, T. (2007). Renaming "chemobrain". Cancer Investigation, 25, 373-377.
22. Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. (2012). Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews, 38, 926-934.
23. Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T.,... The Breast Cancer Survivors' Brain MRI Database Group. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109, 146-156.
24. Jansen, C. E., Miaskowski, C. A., Dodd, M. J., & Dowling, G. A. (2007). A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncology Nursing Forum, 34, 997-1005.
25. Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). A meta-analysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer, 104, 2222-2233.
26. Kohli, S., Griggs, J. J., Jean-Pierre, P., Mustian, K. M., Roscoe, J. A., Wade, J. L., Morrow, G. R. (2006). Self-reported cognitive impair-ment in cancer patients: A URCC CCOP longitudinal study of 595 patients. Journal of Clinical Oncology, 24(18S), 8502.
27. Kreft, I., de Leeuw, J. (1998). Introducing multilevel modeling. Thousands Oaks, CA: Sage.
28. Kyoko, T., Yoshitoku, Y., & Toyonori, O. (2011). Practice guideline of evidence-based medicine: Preferred Reporting Items for Systematic Reviews and Meta-analyses (the PRISMA statement). Journal of Information Processing & Management/Joho Kanri, 54, 254-266.
29. Lipsey, M. K., Wilson, D. B. (2001). Practical meta-analysis. Thousand Oaks, CA: Sage.
30. Lupien, S. J., Wilkinson, C. W., Briere, S., Menard, C., Ng Ying Kin, N. M., & Nair, N. P. (2002). The modulatory effects of corticosteroids on cognition: Studies in young human populations. Psychoneuroendocrinology, 27, 401-416.
31. Maddams, J., Brewster, D., Gavin, A., Steward, J., Elliott, J., Utley, M., & Moller, H. (2009). Cancer prevalence in the United Kingdom: Estimates for 2008. British Journal of Cancer, 101, 541-547.
32. McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study. Breast Cancer Research and Treatment, 123, 819-828.
33. Overton, R. C. (1998). A comparison of fixed-effects and mixed (randomeffects) models for meta-analysis tests of moderator variable effects. Psychological Methods, 3, 354-379.
34. Patel, M. S. (1989). An introduction to meta-analysis. Health Policy, 11, 79-85.
35. Rabash, J., Charlton, C., Browne, W. J., Healy, M., & Cameron, B. (2009). MLwiN Version 2.1 [software]. Bristol, UK: Centre for Multilevel Modelling, University of Bristol.
36. Rosenthal, R., & DiMatteo, M. R. (2001). Meta-analysis: Recent developments in quantitative methods for literature reviews. Annual Review of Psychology, 52, 59-82.
37. Schagen, S. B., Das, E., & Vermeulen, I. (2012). Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients. Psycho-Oncology, 21, 1132-1135.
38. Shilling, V., Jenkins, V., & Trapala, I. S. (2006). The (mis)classification of chemo-fog-methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Research and Treatment, 95, 125-129.
39. Short, P. F., Vasey, J. J., & Tunceli, K. (2005). Employment pathways in a large cohort of adult cancer survivors. Cancer, 103, 1292-1301.
40. Silverman, D. H. S., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., Ganz, P. A. (2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Research and Treatment, 103, 303- 311.
41. Sterne, J. A., Gavaghan, D., & Egger, M. (2000). Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature. Journal of Clinical Epidemiology, 53, 1119 -1129.
42. Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. The Clinical Neuropsychologist, 20, 76-89.
43. Strauss, E., Sherman, E. M. S., & Spreen, O. (2006). A compendium of neuropsychological tests: Administration, norms, and commentary (3rd ed.). New York, NY: Oxford University Press.
44. Terrin, N., Schmid, C. H., Lau, J., & Olkin, I. (2003). Adjusting for publication bias in the presence of heterogeneity. Statistics in Medicine, 22, 2113-2126.
45. Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., & Schagen, S. B. (2008). Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Annals of Oncology, 19, 623-629.
46. von der Weid, N., Mosimann, I., Hirt, A., Wacker, P., Nenadov Beck, M., Imbach, P., Wagner, H. P. (2003). Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: Age- and sex-related differences. European Journal of Cancer, 39, 359-365.
47. Wallace, B. C., Schmid, C. H., Lau, J., & Trikalinos, T. A. (2009). Meta-Analyst: Software for meta-analysis of binary, continuous and diagnostic data. BMC Medical Research Methodology, 9, 80.
48. Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011). International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncology, 12, 703-708.
49. Zachariae, R., & Mehlsen, M. Y. (2011). Is chemotherapy associated with cognitive impairment? Nature Reviews Urology, 8, 182-183.